type: position_score table: filename: ENCFF652FKO.tabix.bed.gz header_mode: none zero_based: true format: tabix chrom: column_index: 0 pos_begin: column_index: 1 pos_end: column_index: 2 scores: - id: TF_ChIP-seq_ENCSR269TNX column_index: 3 type: float desc: signal histogram: type: number number_of_bins: 100 meta: summary: 'ChIP-seq ENCSR269TNX [TISSUE: Homo sapiens HepG2 genetically modified (insertion) using CRISPR targeting H. sapiens GABPA, TARGET: GABPA]' description: '**status**: released **biological\_replicates**: Rep 1, Rep 2 **summary**: genetically modified (insertion) using CRISPR targeting H. sapiens GABPA **output\_type**: IDR thresholded peaks **audit\_internal\_action**: Released analysis {ENCAN196HDA|/analyses/ENCAN196HDA/} has in progress subobject quality standard {encode4-tf-chip|/quality-standards/encode4-tf-chip/} **audit\_internal\_action**: Released analysis {ENCAN196HDA|/analyses/ENCAN196HDA/} has in progress subobject document {606db5a2-9302-4049-8a19-be49dd7a5338|/documents/606db5a2-9302-4049-8a19-be49dd7a5338/} **audit\_warning**: Processed alignments file {ENCFF701TAB|/files/ENCFF701TAB/} processed by ChIP-seq ENCODE4 v1.6.1 GRCh38 pipeline has 18617471 usable fragments. The minimum ENCODE standard for each replicate in a ChIP-seq experiment targeting GABPA-human and investigated as a transcription factor is 10 million usable fragments. The recommended value is > 20 million, but > 10 million is acceptable. (See {ENCODE ChIP-seq data standards|/data-standards/chip-seq/} )' labels: reference_genome: hg38/genomes/GRCh38-hg38 accession: ENCSR269TNX status: released assay_term_name: ChIP-seq simple_biosample_summary: genetically modified (insertion) using CRISPR targeting H. sapiens GABPA biosample_summary: Homo sapiens HepG2 genetically modified (insertion) using CRISPR targeting H. sapiens GABPA replication_type: isogenic biosample_ontology: /biosample-types/cell_line_EFO_0001187/ perturbed: false doi: 10.17989/ENCSR269TNX date_created: '2016-07-28T18:55:07.734389+00:00' date_released: '2016-10-31' submitter_comment: '' target: GABPA